Wednesday, January 26, 2022 1:51:47 PM
https://www.nih.gov/activ/nih-funded-activ/activ-associated-clinical-trial.
As you can see it includes repurposed drugs like Aspirin and Ivermectin as well as the latest monoclonal antibodies. Most of the drugs are anti-inflammatories. A few are antivirals.
When you review the list, it is not impressive.It is surprising how few drugs are left to be tested against Covid. These drugs are a last ditch effort by the NIH to find any drug with any degree of efficacy against Covid.
Let me know if you find one with where government sponsored in vitro testing against Covid produced a selectivity index of 426.
I believe IPIX, as it has stated publicly, is actively pursuing inclusion in the ACTIV trials. I believe it is important to pursue the Activ testing of Brilacidin against Covid by itself and in combination with different drugs at different stages of Covid. Of course the NIH will make the decision
GLTA,
Farrell
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM